NCT05474859View on ClinicalTrials.gov

Subjects With Advanced or Metastatic Solid Tumor Malignancies

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

June 30, 2028

Conditions

Metastatic Solid TumorAdvanced Solid Tumor

Interventions

DRUG

XT-0528

Once Daily

All Listed Sponsors

lead

Xenthera, Inc.

INDUSTRY